icrovolt T-wave alternans (TWA) is a measure of ventricular repolarization abnormality. Many clinical studies have shown that this marker is a strong predictor of sudden cardiac death (SCD) and cardiac mortality in the setting of myocardial infarction (MI). 1-4 Recent studies have reported that TWA using the modified moving average method (MMA-TWA) based on the time-domain algorithm of TWA measurement, which can be assessed simply using 24-h Holter ECGs is also a significant index for cardiac events. [5] [6] [7] Heart rate turbulence (HRT) is a measure of autonomic response to perturbation of arterial blood pressure after ventricular premature contractions (VPCs) and has been also introduced as a risk stratification marker for serious cardiac events. 8- 11 However, no prospective study has described the clinical utility of these markers in a simultaneous assessment, and there is no available information of a comparison of the 2 markers for risk stratification for serious cardiac events.
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In the present study, we simultaneously recorded MMA-TWA and HRT in patients after MI and designed a prospective observational study to compare the clinical utility of the 2 markers in predicting cardiac mortality and fatal arrhythmic events.
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TWA and HRT After MI diagnosis of MI between June 2006 and January 2010. Exclusion criteria were chronic atrial fibrillation, use of an implanted permanent pacemaker, and cardiac resynchronization therapy. After enrollment, 15 patients were excluded from the study because 10 had paroxysmal atrial tachyarrhythmias and 5 had an intraventricular conduction disturbance such as left or right bundle brunch block during the recording of the markers. These exclusion criteria were based on inability to perform MMA-TWA and HRT determination or reliable data analysis. Accordingly, 313 post-MI patients (age 70±12 years, 232 men) were included.
The clinical characteristics of post-MI patients are listed in Table 1 . The diagnosis of MI was based on clinical course, serum creatine kinase activity, and ST-segment elevation on ECG. In this study population, most patients underwent revascularization of one or more coronary lesions in the acute phase, consisting of percutaneous coronary intervention or coronary artery bypass graft surgery. All patients had a New York Heart Association functional class of I or II at HRT assessment. Thus, most patients in this study had relatively preserved cardiac function. The mean left ventricular ejection fraction (LVEF) was 47±11%.
Informed consent was given by each patient and the study was approved by the Ethics Committee of Kyorin University Hospital.
Measurement of MMA-TWA
The MMA-TWA was assessed using a commercial system (MARS PC system, GE Healthcare Inc, Milwaukee, WI, USA). 5, 12 The assessment was done in the stable phase of MI (usually >2 weeks after onset). The MMA method was designed to allow TWA analysis during exercise and ambulatory monitoring. 13 MMA-TWA was analyzed in leads V5 (CM5) and V1 (NASA) from routine 24-h Holter ECG recordings without an exercise protocol. 7 The MMA algorithm separates odd and even beats into separate bins and creates median templates for both the odd and even complexes every 15 s. The templates are superimposed, and the entire JT segment is analyzed for alternation. The difference between the odd and even median complexes at any point is defined as the MMA-TWA value. These templates of superimposed complexes can be examined visually to verify MMA-TWA presence and magnitude. The MMA allows control of the influence of new incoming complexes on the median templates with an adjustable update factor. The update factor of the moving average used for acquisition of data was 1/8. The maximal MMA-TWA voltage at a heart rate <120 beats/min was derived automatically in 2 leads. After that, manual editing was performed by 2 cardiologists if the data were not available because of noise or artifacts.
In this study, the greater maximal voltage of MMA-TWA in the 2 leads was chosen for assessment. MMA-TWA was determined positive when the voltage was >64 μV. 7 
Measurement of HRT
HRT was simultaneously measured using the same 24-h Holter ECG recordings as for MMA-TWA measurement. HRT parameters included turbulence onset (TO) and turbulence slope (TS), which were determined according to a previously published method. 8 The TO and TS were dichotomized at predefined cut points (TO=0%, TS=2.5 ms/RR interval).
In this study, patients were defined as HRT positive when both TO and TS were abnormal (TO >0% and TS <2.5 ms/RR interval), and as HRT negative when TO and/or TS were normal (TO ≤0% and/or TS ≥2.5 ms/RR interval) or when HRT could not be calculated because of none or too few suitable VPCs. 10,14,15
Assessment of Other Clinical Factors
In this study, the following risk predictors were also prospectively assessed: age and sex of the patients, LVEF measured from the echocardiographic data using a modified Simpson's method, a history of diabetes mellitus, chronic kidney disease, hypertension, and hypercholesterolemia, use of medical treatment such as aspirin, β-blockers, statins, angiotensin-converting enzyme inhibitors/angiotensin-receptor blockers, class III antiarrhythmic drugs, and implantable cardioverter defibrillator (ICD), and the presence of nonsustained ventricular tachycardia (NSVT).
The presence NSVT was determined from the same 24-h Holter ECG recordings during daily activities as for the MMA-TWA and HRT measurements. According to previous reports, 16 NSVT was identified as 3 or more consecutive ventricular extrasystoles at a rate >100 beats/min.
Follow-up and Study Endpoints
All patients were followed as outpatients at Kyorin University Hospital. Regular follow-up contact was obtained at hospital visits every 2 or 4 weeks. When patients did not visit for more than 8 weeks, medical staff conducted telephone interviews.
The endpoint was overall cardiac mortality and fatal arrhythmic events defined as SCD, ventricular fibrillation, and sustained VT. In patients who died, the causes were verified from the hospital and autopsy records, and from either the primary physicians or those who had witnessed the death. Patients who died of non-cardiac causes such as malignancies, and stroke were not included in the endpoints. For fatal arrhythmic events, the records were verified from monitoring ECGs taken in the emergency room, ambulatory ECGs captured out-of-hospital, or by checking the ICD's memory. In patients with an ICD, an appropriate episode of defibrillation therapy and antitachycardia pacing were included in the fatal arrhythmic events. 
Results

MMA-TWA, HRT and Clinical Factors
The average value of MMA-TWA measured from 24-h Holter ECGs was 29±20 μV under a mean heart rate of 75±16 beats/min. MMA-TWA was determined as positive in 14 patients (4.5%) and negative in the remaining 299 patients (95.5%). Average values for TO and TS were −0.27±2.32% (abnormal in 106 patients [34%]) and 5.30±6.55 ms/RR interval (abnormal in 106 patients [34%]), respectively. According to the data, HRT was determined as positive in 61 patients (19.5%) and negative in the remaining 252 patients (80.5%).
Average LVEF was 47±11% and NSVT was documented on Holter ECGs in 53 patients (17%).
Comparisons of the clinical characteristics of positive and negative patients for MMA-TWA and HRT are listed in Tables 2 and 3, respectively.
Cardiac Events During Follow-up
Follow-up was completed in all patients and no patient was lost to follow-up. Three patients died from non-cardiac causes (lung cancer, leukemia, and intestinal pneumonia) during follow-up; these patients were therefore excluded from the study endpoint. During the mean follow-up period of 1,190±441 days, 28 patients (9%) reached the endpoint, including 16 patients who died from heart failure progression, 6 patients suffering from SCD, and 6 patients suffering fatal arrhythmic events including 1 patient suffering from defibrillation therapy for ventricular fibrillation among the patients with an ICD. For defined fatal arrhythmic events, a total of 12 patients reached the endpoint.
Association Between Risk Markers and Endpoints
On univariate analysis, age, LVEF, diabetes, hypertension, hypercholesterolemia, chronic renal disease, documentation of NSVT, HRT-positive outcome and MMA-TWA-positive outcome were significantly associated with the endpoint (P=0.0133, P<0.0001, P<0.0001, P=0.0057, P=0.058, P<0.0001, P<0.0001, P<0.0001 and P=0.0174, respectively) ( Table 4) . To test which factor was the most significant, we performed a multivariate analysis and HRT-positive outcome was the most significant predictor for the endpoint (HR 5.7, 95% CI 2.1-15.9; P=0.0008). Figure 1 shows the Kaplan-Meier event-free curves for the endpoint (cardiac mortality and fatal arrhythmic events) based on HRT-positive and MMA-TWA-positive outcomes in the study patients (P<0.0001).
HRT-and MMA-TWA-positive outcomes had a sensitivity of 71% and 14%, specificity of 86% and 97%, positive predictive value of 33% and 29%, negative predictive value of 97% and 92%, and predictive accuracy of 84% and 89%, respectively, in predicting the endpoint.
When focused on fatal arrhythmic events, LVEF, diabetes, documentation of NSVT, HRT-positive outcome and MMA-TWA-positive outcome were significantly associated with the endpoint on univariate analysis (P=0.0007, P=0.0046, P=0.0001, P=0.0002 and P=0.0001, respectively) ( Table 5) . To test which factor was the most significant, we performed a multivariate analysis and MMA-TWA-positive outcome was the most sig- Figure 2 shows the Kaplan-Meier event-free curves for fatal arrhythmic events (SCD, ventricular fibrillation, and sustained VT) based on HRT-positive and MMA-TWA-positive outcomes in the study patients (P=0.0009).
Discussion
The present study revealed that MMA-TWA and HRT are independent predictors of serious cardiac events in patients after MI. Both markers have a negative predictive value that is high enough to screen patients at risk of serious cardiac Figure 1 . Kaplan-Meier event-free curves for the endpoint (cardiac mortality and fatal arrhythmic events) based on HRT-positive and MMA-TWA-positive outcomes in study patients. HRT, heart rate turbulence; MMA, modified moving average method; TWA, T-wave alternans. events. The results also demonstrated that MMA-TWA is more associated with arrhythmic events than cardiac mortality from heart failure progression in post-MI patients.
Clinical Significance of MMA-TWA Several studies support the clinical usefulness of MMA-TWA. 5-7,13,17,18 A case-control subanalysis from the ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) study revealed that MMA-TWA obtained from ambulatory ECGs is a promising approach to risk stratification for arrhythmic death in relatively low-risk post-MI patients. 13 A casecontrol subanalysis from EPHESUS (the Eplerenone PostAcute Myocardial Infarction Heart Failure Efficacy and Survival Study) also revealed that MMA-TWA obtained from ambulatory ECGs is a powerful predictor of SCD in post-MI patients with LV dysfunction. 6 Those 2 studies were retrospective analyses, and a prospective study demonstrated that MMA-TWA measured from 24-h Holter ECGs also predicts cardiac mortality in patients with ischemic and non-ischemic LV dysfunction. 7 Two other prospective studies that measured MMA-TWA during or after exercise tests showed that this marker powerfully predicts cardiac mortality in patients after MI and in a population undergoing a clinically indicated exercise test. 4,18 All of these studies, 4,6,7,13 except for one, 18 assessed the clinical usefulness of MMA-TWA in post-MI patients with and without LV dysfunction. The FINCAVAS study and REFINE study also showed that MMA-TWA using routine excise protocol is significant predictor of SCD or cardiovascular mortality in larger cohort. We focus on whether the MMA method was designed to allow TWA analysis during 24-h Holter ECG recording. The present study is the first prospective study to demonstrate the utility of MMA-TWA in patients following MI as measured from routine 24-h Holter ECG during daily activity; in other words, without an exercise protocol. The result of this study is helpful information about assessing MMA-TWA in patients who have physical problems or in whom it is too difficult to increase the heart rate because of β-blockers or other medications.
Clinical Significance of HRT
HRT has also been introduced as an autonomic risk-stratification marker of serious cardiac events after MI. 8-11,14, 15 Patients after MI often have frequent paroxysmal ventricular contractions (PVCs), in which case it is difficult to assess TWA, including MMA-TWA, because the assessment is calculated using alternating change of T-wave morphology. In such cases, HRT is a useful tool because the assessment of HRT needs a number of PVCs. When post-MI patients have a wide QRS complex, it is also difficult to analyze MMA-TWA, but not HRT.
According to the results of the present study, HRT is a strong predictor of cardiac mortality and fatal arrhythmic events and has a high negative predictive value in patients after MI. Therefore, HRT could be useful in post-MI patients with frequent PVCs and intraventricular conduction disturbance.
Comparison of MMA-TWA and HRT as Predictors
Although previous studies showed that each of MMA-TWA and HRT is a significant predictor for SCD and/or cardiovascular mortality, this is the first report to demonstrate simultaneous measurement of the 2 markers and to compare the predictive accuracy between them for both cardiac mortality and arrhythmic events.
This prospective study revealed that MMA-TWA and HRT have different clinical features as risk stratification markers. MMA-TWA was more associated with fatal arrhythmic events than with cardiac mortality because of heart failure progression. Conversely, HRT was more associated with cardiac mortality from heart failure progression than with fatal arrhythmic Figure 2 . Kaplan-Meier event-free curves for fatal arrhythmic events (sudden cardiac death, ventricular fibrillation, and sustained ventricular tachycardia) based on HRT-positive and MMA-TWA-positive outcomes in study patients. HRT, heart rate turbulence; MMA, modified moving average; TWA, T-wave alternans. HOSHIDA K et al.
events. MMA-TWA may tend to predict fatal arrhythmic events, including SCD, whereas HRT may tend to predict cardiac mortality, particularly mortality from heart failure progression. As regards MMA-TWA, the incidence of NSVT and degree of LVEF in the patient's clinical background did not differ between the positive and negative patients, whereas these factors significantly differed between HRT-positive and -negative patients. These results suggest that MMA-TWA is a significant predictor that is more independent of the trigger of serious arrhythmias and degree of cardiac function than HRT in patients after MI. In other words, HRT correlate more to the trigger of serious arrhythmias and degree of cardiac function than MMA-TWA.
Study Limitations
Because of the limited scope of our study, we did not include microvolt TWA. 19,20 heart rate variability, 21 baroreflex sensitivity, 21 and other ECG markers, 22,23 which would be significant predictors. We do not know the effect of these markers on cardiac death or arrhythmic events in this study population. Many studies have shown that antiarrhythmic drug and β-blocker therapies at the acute phase of MI affect prognosis in patients with MI. 24 Similarly, we do not know the effect of these drugs in this study.
This study has a limitation regarding the study population for the MMA-TWA and HRT measurements. In the present study, we excluded patients who had chronic/paroxysmal atrial tachyarrhythmias, intraventricular conduction disturbance, and use of an implanted permanent pacemaker or cardiac resynchronization therapy because of the inability to perform the tests or reliable data analysis. These exclusion criteria may affect outcomes of the present study. Because paroxysmal atrial tachyarrhythmias and intraventricular conduction disturbance were occasionally observed in the acute phase of MI, simultaneous MMA-TWA and HRT determination tests may be applied only in the stable state after MI.
